Tool for Making Informed Decisions to Aid Timely Management of Parkinson's Disease

Background

MANAGE-PD is a collaborative research and development effort between AbbVie Inc. Medical Affairs and Health Economics and Outcomes, the Parkinson’s Foundation and an international panel of Movement Disorder Specialists. Each panelist was selected solely by AbbVie and has received financial support from AbbVie for research, honoraria and/or consulting services depending on the author. See Conference Abstracts below for more information.

Parkinson’s Foundation. AbbVie and the Parkinson’s Foundation by written agreement collaborated to develop the idea for the MANAGE-PD tool and this site. AbbVie has compensated the Parkinson’s Foundation for its time and resources.

Conference Abstracts

Financial support for the validation study was provided by AbbVie and AbbVie participated in the study design, research, data collection, analysis and interpretation of data, writing, reviewing and approving the abstract. All authors contributed to the development of the abstract and maintained control over the final content. A disclosure including financial relationship to AbbVie for each author is found in the abstract. All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for the abstract.

Validation Publications

Antonini A, Odin P, Schmidt P, Cubillos F, Standaert D, Henriksen T, Jimenez-Shahed J, Alobaidi A, Jalundhwala Y, Bao Y, Zamudio J, Parra JC, Kukreja P, Onuk K, Skalicky A, Kleinman L, Jones E, Metz S, Fernandez HH. Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications. Parkinsonism Relat Disord. 2021 Nov;92:59-66.

Antonini A, Pahwa R, Odin P, Henriksen T, Soileau MJ, Rodriguez-Cruz R, Isaacson SH, Merola A, Lindvall S, Domingos J, Alobaidi A, Jalundhwala YJ, Kandukuri PL, Parra JC, Kukreja PK, Onuk K, Bergmann L, Pike J, Ray Chaudhuri K. Psychometric Properties of Clinical Indicators for Identification and Management of Advanced Parkinson's Disease: Real-World Evidence From G7 Countries. Neurol Ther. 2022 Jan 11. doi: 10.1007/s40120-021-00313-9.

Responsive Image